Dr. Jennifer Perusini, a neuroscientist and entrepreneur, is the Founder and Chief Executive Officer of Neurovation Labs. Dr. Perusini’s doctoral work forms the basis of Neurovation Labs’ pioneering research, which made the groundbreaking discovery that there is a physiological component to Post-Traumatic Stress Disorder (PTSD) that can be targeted to both diagnose and treat the disorder. Dr. Perusini and her team have developed a patent pending detection method and are currently creating a companion treatment for PTSD.
Dr. Perusini earned her B.A. in Neuroscience & Behavior at Barnard College, Columbia University, and her Ph.D. in Behavioral Neuroscience at the University of California, Los Angeles, where she studied the mechanisms underlying PTSD in an animal model. She completed her post-doctoral fellowship, which focused on rodent models of aging and Alzheimer’s disease, at Columbia University in the Departments of Psychiatry and Integrative Neuroscience.
Dr. Perusini and Neurovation Labs have been featured in numerous publications, including AlleyWatch, the leading publication dedicated to start-ups in New York City, and Biocentury, a biopharmaceutical publication. She has also been a guest speaker on numerous biotech, military, and mental health podcasts and radio shows. She is a presenter at national biotech industry events, and frequently speaks on issues pertaining to entrepreneurs across industries. Dr. Perusini is also a board member of Women in Learning (WIL), a nationwide organization dedicated to the support and advancement of women in science.